![]() |
NEW MEXICO | 300 Oak Street NE Albuquerque, NM 87106 |
|||||||||||||||||||||
CLINICAL RESEARCH & OSTEOPOROSIS CENTER |
Phone: 505-855-5525 Fax: 505-884-4006 |
||||||||||||||||||||||
| -------------------E. Michael Lewiecki, MD, FACP, FACE - Osteoporosis Director -|- Lance A. Rudolph, MD - Research Director | |||||||||||||||||||||||
|
NewslettersSpring 2009Worldwide Economic Crisis The stock market crash, downturn in real estate values, and severe limitations in lending have affected all of us in one way or another. Skyrocketing health insurance premiums have contributed to the financial stress of individuals and businesses, with the federal government rightfully taking a serious look at healthcare reform. There is danger, however, that the baby (in this case, osteoporosis care) may be thrown out with the bathwater. At the same time the Surgeon General is telling us to do more in caring for osteoporosis, other federal agencies and the private insurance industry are making it more difficult to do so. Medicare has reduced the reimbursement for bone density testing to a point that most facilities are not being paid enough to cover the cost of doing the test. This has resulted in the closing of some facilities, with the eventual result that access to needed diagnostic services will be limited, with fewer patients being diagnosed with osteoporosis, fewer treated, and more fractures. Aside from the personal suffering caused by fractures, this has been estimated to cost Medicare (and the taxpayers) an extra $1.1 billion in fracture-related expenses over the next 5 years. But there is more. Medicare and health plans do not cover bone density testing for all patients who need it, and are restricting the use of this test to monitor patients being treated. Other useful osteoporosis tests, such as the measurement of vitamin D levels and bone turnover markers (See side bar on back page) are now commonly being denied.
E. Michael Lewiecki, MD This page update 04/11/09
|
|
|||||||||||||||||||||